Singhai Rajeev, Patil Vw, Patil Av
Department of Biochemistry, Grant Medical College and Sir J J Group of Hospitals, Mumbai - 400 008, Maharashtra, India.
Int J Appl Basic Med Res. 2011 Jan;1(1):15-9. doi: 10.4103/2229-516X.81974.
Breast cancer is a leading cause of death in women. Receptor status is the most important prognostic and predictive marker for breast cancer.
The present study was conducted with an aim to analyze breast cancer of Indian women with discordant receptor status, probably hormone dependent estrogen receptor (ER) positive, progesterone receptor (PgR) negative or ER- negative and PgR+ positive subgroup profile, infiltrating ductal breast cancer (IDC) not otherwise specified.
Specimens from 100 IDC were grouped into three categories according to hormonal status (group 1: ER+ positive and PgR+ positive, group 2: ER+ positive and PgR- negative or ER- negative and PgR+ positive, group 3: ER- negative and PgR- negative) evaluated prognostic parameters.
Statistically significant difference was found between tumor receptor status distribution and menopausal status (P = 0.0235), age of patients (P < 0.001), histopathologic grade (P < 0.001), vascular invasion (P = 0.006), HER-2/neu status (P = 0.004) and Ki-67 proliferation rate (P < 0.001).
Group 1 tumors were found exclusively in post-menopausal patients with average age 68.9 years, most of which had intermediate grade II, without vascular invasion, with HER-2/neu status score predominantly 0 or 1+ and lower Ki-67 proliferation rate. Group 2 tumors were found predominantly in younger post-menopausal patients with average age 57.5 years, with vascular invasion found in 23% of cases. Group 3 tumors mostly had higher histopathologic grade, showed the highest percentage of the Ki-67 positive tumor cells and vascular invasion in 30% of the cases.
It is concluded that patients with group 2 breast cancer were younger post-menopausal women, with tumors moderately differentiated, HER-2/neu score 0 or 1+ and with lower Ki-67 proliferation rate.
乳腺癌是女性死亡的主要原因。受体状态是乳腺癌最重要的预后和预测标志物。
本研究旨在分析印度女性受体状态不一致的乳腺癌,可能为激素依赖性雌激素受体(ER)阳性、孕激素受体(PgR)阴性或ER阴性且PgR阳性亚组特征,未另行指定的浸润性导管癌(IDC)。
根据激素状态将100例IDC标本分为三类(第1组:ER阳性且PgR阳性,第2组:ER阳性且PgR阴性或ER阴性且PgR阳性,第3组:ER阴性且PgR阴性),评估预后参数。
发现肿瘤受体状态分布与绝经状态(P = 0.0235)、患者年龄(P < 0.001)、组织病理学分级(P < 0.001)、血管侵犯(P = 0.006)、HER-2/neu状态(P = 0.004)和Ki-67增殖率(P < 0.001)之间存在统计学显著差异。
第1组肿瘤仅见于绝经后患者,平均年龄68.9岁,大多数为中等II级,无血管侵犯,HER-2/neu状态评分主要为0或1+,Ki-67增殖率较低。第2组肿瘤主要见于绝经后年轻患者,平均年龄57.5岁,23%的病例有血管侵犯。第3组肿瘤大多组织病理学分级较高,Ki-67阳性肿瘤细胞百分比最高,30%的病例有血管侵犯。
得出结论,第2组乳腺癌患者为绝经后年轻女性,肿瘤中度分化,HER-2/neu评分为0或1+,Ki-67增殖率较低。